Back
Regeneron Pharmaceuticals Vs. Puma Biotechnology Industry Stock Comparison
Buy
66
REGN
Regeneron Pharmaceuticals
Last Price:
937.69
Seasonality Move:
11.17%
Sell
44
PBYI
Puma Biotechnology
Last Price:
4.96
Seasonality Move:
29.48%
Buy
66
Regeneron Pharmaceuticals (REGN)
is a Buy
Is Regeneron Pharmaceuticals a Buy, Sell or Hold?
- The current Regeneron Pharmaceuticals [REGN] share price is $937.61. The Score for REGN is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- REGN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Puma Biotechnology (PBYI)
is a Sell
Is Puma Biotechnology a Buy, Sell or Hold?
- The current Puma Biotechnology [PBYI] share price is $4.94. The Score for PBYI is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- PBYI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals's stock price today?
-
The Regeneron Pharmaceuticals share price today is $937.61
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing buying pressure, which is a positive indicator for future bullish movement.
PBYI Stock Price Chart
What is Puma Biotechnology's stock price today?
-
The Puma Biotechnology share price today is $4.94
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PBYI is experiencing buying pressure, which is a positive indicator for future bullish movement.
REGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -10.75 | Sell |
| Relative Strength Index (14 RSI): | 58.23 | Buy |
| Chaikin Money Flow: | 812801 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (892.62 - 943.74) | Buy |
| Bollinger Bands (100): | (889.44 - 968.02) | Buy |
PBYI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.12 | Sell |
| Relative Strength Index (14 RSI): | 42.84 | Sell |
| Chaikin Money Flow: | 211065 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.97 - 5.49) | Sell |
| Bollinger Bands (100): | (4.4 - 5.9) | Sell |
REGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 901.38 | Buy |
| 20-day SMA: | 909.03 | Buy |
| 50-day SMA: | 944.29 | Sell |
| 200-day SMA: | 867.65 | Buy |
| 8-day EMA: | 906.16 | Buy |
| 20-day EMA: | 912.49 | Buy |
| 50-day EMA: | 926.19 | Buy |
| 200-day EMA: | 877.13 | Buy |
PBYI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.98 | Sell |
| 20-day SMA: | 5.2 | Sell |
| 50-day SMA: | 5.39 | Sell |
| 200-day SMA: | 4.21 | Buy |
| 8-day EMA: | 5 | Sell |
| 20-day EMA: | 5.12 | Sell |
| 50-day EMA: | 5.23 | Sell |
| 200-day EMA: | 4.51 | Buy |
Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.26 per share, an increase next quarter of $0.00 per share, an increase this year of $2.59 per share, and an increase next year of $2.21 per share.
Puma Biotechnology Earnings Growth & PBYI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $0.02 per share.
Regeneron Pharmaceuticals Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Puma Biotechnology Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||